Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0022 USD | -99.72% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Capitalization 1 | 48.53 | 48.53 | 310.2 | 328.7 | 80.44 | 61.88 |
Enterprise Value (EV) 1 | 48.89 | 48.59 | 310.2 | 329.1 | 80.81 | 62.24 |
P/E ratio | -248 x | 157 x | -3,511 x | -2,607 x | -315 x | -1,481 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -307 x | 194 x | - | - | - | - |
EV / FCF | 945 x | -498 x | -2,062 x | -1,120 x | 338 x | 4,289 x |
FCF Yield | 0.11% | -0.2% | -0.05% | -0.09% | 0.3% | 0.02% |
Price to Book | -93.7 x | -232 x | -5,038 x | -1,751 x | -182 x | -128 x |
Nbr of stocks (in thousands) | 32,350 | 32,350 | 77,350 | 77,350 | 77,350 | 77,350 |
Reference price 2 | 1.500 | 1.500 | 4.010 | 4.250 | 1.040 | 0.8000 |
Announcement Date | 3/29/17 | 4/16/18 | 3/19/19 | 5/14/20 | 4/14/21 | 3/31/22 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -0.1593 | 0.251 | - | - | - | - |
EBIT 1 | -0.1787 | 0.2317 | -0.0673 | -0.1127 | -0.0506 | -0.05 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.1956 | 0.3087 | -0.0884 | -0.1262 | -0.255 | -0.0418 |
Net income 1 | -0.1956 | 0.3087 | -0.0884 | -0.1262 | -0.255 | -0.0418 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.006047 | 0.009541 | -0.001142 | -0.001630 | -0.003297 | -0.000540 |
Free Cash Flow 1 | 0.0518 | -0.0976 | -0.1504 | -0.2937 | 0.2388 | 0.0145 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/29/17 | 4/16/18 | 3/19/19 | 5/14/20 | 4/14/21 | 3/31/22 |
Balance Sheet Analysis
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.36 | 0.07 | 0.03 | 0.38 | 0.36 | 0.36 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -2.277 x | 0.2786 x | - | - | - | - |
Free Cash Flow 1 | 0.05 | -0.1 | -0.15 | -0.29 | 0.24 | 0.01 |
ROE (net income / shareholders' equity) | 46.5% | -84.9% | 65.2% | 101% | 80.9% | 9.02% |
ROA (Net income/ Total Assets) | -47.1% | 127% | -719% | -55.7% | -23.6% | -148% |
Assets 1 | 0.4152 | 0.2422 | 0.0123 | 0.2267 | 1.083 | 0.0283 |
Book Value Per Share 2 | -0.0200 | -0.0100 | -0 | -0 | -0.0100 | -0.0100 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 3/29/17 | 4/16/18 | 3/19/19 | 5/14/20 | 4/14/21 | 3/31/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 170K | |
+108.23% | 6.92B | |
+2.71% | 988M | |
+51.02% | 987M | |
+2.39% | 668M | |
-.--% | 600M | |
-3.05% | 593M | |
+10.28% | 536M | |
-.--% | 500M | |
+4.83% | 470M |
- Stock Market
- Equities
- BENH Stock
- Financials Bio-En Holdings Corp